Hospitals worldwide seek to participate in the study.

Israel’s BioLight Life Sciences has completed a successful US clinical study designed to assess the effectiveness of a test evaluating tears’ components of patients suffering from dry eye syndrome, and Israeli startup SoniVie has a novel system for the treatment of pulmonary arterial hypertension.